DEALSTREETASIA | China: SDIC invests $72m in Ascentage Series B; iGola raises $19m DEALSTREETASIA Ascentage Pharma, a Jiangsu province-based biopharmaceutical company dedicated to the discovery of targeted small-molecule cancer therapeutics, secured $72 million (RMB500 million) in a Series B round led by a fund under China's SDIC Fund ... |